Expression and significance of LRIG3 in human cervical squamous cell carcinoma

Objective: To explore the effect of LRIG3 in the development of cervical squamous cell carcinoma. Materials and Methods: LRIG3 and epidermal growth factor receptor (EFGR) expressions were detected by immunohistochemistry. Western blot method was used to detect LRIG3 and EGFR protein expression at different time points. MTT, flow cytometry, and transwell chamber were adopted to examine the proliferation, apoptosis, and strength of invasion of Hela229 cell respectively. Results: During the process of normal cervix deteriorating into CIN and CSCC, LRIG3 expression gradually decreased, while EGFR increased. After the transfection of LRIG3 ASODN into cells, the amount of LRIG3 expression and the cell apoptosis rate both decreased gradually, EGFR protein expression and cell proliferation rate both increased (p < 0.05), other groups remained unchanged (p > 0.05). The cell migration ability in LRIG3 ASODN transfection group was stronger than that of other groups (p < 0.05). Conclusion: LRIG3 plays an important role in Hela229 cell proliferation, apoptosis, and invasiveness.

LRIG3; Cervical squamous carcinoma; Immunohistochemical method; EGFR.

[1] Yang L., Jia X., Li N., Chen C., Liu Y., Wang H.: “Comprehensive clinic-pathological characteristics of cervical cancer in southwestern China and the clinical significance of histological type and lymph node metastases in young patients”. PLoS One, 2013, 8, 10.

[2] Woodworth C.D., Diefendorf L.P., Jette D.F., Mohammed A., Moses M.A., Searleman S.A., et al.: “Inhibition of the epidermal growth factor receptor by erlotinib prevents immortalization of human cervical cells by Human Papillomavirus type 16”. Virology, 2011, 421, 1.

[3] Ma D., Hovey R.L., Zhang Z., Fye S., Huettner P.C., Borechi I.B., et al.: “Genetic variations in EGFR and ERBB4 increase susceptibility to cervical cancer”. Gynecol. Oncol., 2013, 6, 13.

[4] Wang Y., Poulin E.J., Coffey R.J.: “LRIG1 is a triple threat: ERBB negative regulator, intestinal stem cell marker and tumour suppressor”. Br. J. Cancer, 2013, 108, 9.

[5] Li Y., Tian B., Yang J., Zhao L., Wu X., Ye S.L., et al.: “Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics”. J. Cancer Res. Clin. Oncol., 2004, 130, 8.

[6] Del Rio T., Nishitani A.M., Yu W.M., Goodrich L.V.: “In vivo analysis of lrig genes reveals redundant and independent functions in the inner ear”. PLoS One, 2013, 9, 9.

[7] Citri A., Yarden Y.: “EGF-ERBB signaling: towards the systems level”. Nat. Rev. Mol. Cell Biol., 2006, 7, 505.

[8] Muller S., Lindquist D., Kanter L., Flores-Staino C., Henriksson R., Hedman H., et al.: “Expression of LRIG1 and LRIG3 correlates with human papillomavirus status and patient survival in cervical adenocarcinoma”. Int. J. Oncol., 2013, 42, 1.

[9] Guo D., Nilsson J., Haapasalo H., Raheem O., Bergenheim T., Hedman H., et al.: “Perinuclear leucine-rich repeats and immunoglobulinlike domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors”. Acta Neuropathol., 2006, 111, 238. Epub 2006 Mar 11.

[10] Cai MJ, Xie RF, Han L, Chen RD, Wang BF, Ye F, et al.: “Effect of RNAi-mediated LRIG3 gene silencing on proliferation of glioma GL15 cells and expression of PCNA and Ki-67”. Ai Zheng, 2009, 28, 1.

[11] Nilsson J, Vallbo C, Guo D, Golovleva I, Hallberg B, Henriksson R, et al.: “Cloning, characterization and expression of human LIG1”. Biochem. Biophys. Res. Commun., 2001, 284, 5.

[12] Fei Ye, Dongsheng Guo, Hongjuan Niu, Shengzhong Tao, Yibo Ou, Yunping Lu, et al.: “Molecular Mechanism of LRIGl Cdna- induced Apoptosis in Human Glioma Cell Line H4”, Cancer, 2004, 23, 1149.